These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 29653218)
21. Continuity of prescribers of short-acting beta agonists among children with asthma. Dombkowski KJ; Harrison SR; Cohn LM; Lewis TC; Clark SJ J Pediatr; 2009 Dec; 155(6):788-94. PubMed ID: 19683253 [TBL] [Abstract][Full Text] [Related]
22. Characteristics of acute asthma patients attended frequently compared with those attended only occasionally in an emergency department. Fernandes AK; Mallmann F; Steinhorst AM; Nogueira FL; Avila EM; Saucedo DZ; Machado FJ; Raymundi MG; Barreto SS; Dalcin Pde T J Asthma; 2003 Sep; 40(6):683-90. PubMed ID: 14580000 [TBL] [Abstract][Full Text] [Related]
23. Overuse of short-acting beta-agonist bronchodilators in COPD during periods of clinical stability. Fan VS; Gylys-Colwell I; Locke E; Sumino K; Nguyen HQ; Thomas RM; Magzamen S Respir Med; 2016 Jul; 116():100-6. PubMed ID: 27296828 [TBL] [Abstract][Full Text] [Related]
24. Application of multicategory exposure marginal structural models to investigate the association between long-acting beta-agonists and prescribing of oral corticosteroids for asthma exacerbations in the Clinical Practice Research Datalink. Ali AK; Hartzema AG; Winterstein AG; Segal R; Lu X; Hendeles L Value Health; 2015 Mar; 18(2):260-70. PubMed ID: 25773561 [TBL] [Abstract][Full Text] [Related]
26. Effectiveness of Population Health Management Using the Propeller Health Asthma Platform: A Randomized Clinical Trial. Merchant RK; Inamdar R; Quade RC J Allergy Clin Immunol Pract; 2016; 4(3):455-63. PubMed ID: 26778246 [TBL] [Abstract][Full Text] [Related]
27. Effect of age on the conformity rate to short-acting beta-agonist use criteria in asthma. Labrecque M; Laurier C; Champagne F; Kennedy W; Paré M; Cartier A J Asthma; 2003; 40(7):829-35. PubMed ID: 14626340 [TBL] [Abstract][Full Text] [Related]
28. Risk of all-cause hospitalization in COPD patients initiating long-acting or short-acting beta agonist therapy. Bollu V; Ejzykowicz F; Rajagopalan K; Karafilidis J; Hay JW J Med Econ; 2013 Aug; 16(8):1082-8. PubMed ID: 23777224 [TBL] [Abstract][Full Text] [Related]
29. Inadequate follow-up controller medications among patients with asthma who visit the emergency department. Cydulka RK; Tamayo-Sarver JH; Wolf C; Herrick E; Gress S Ann Emerg Med; 2005 Oct; 46(4):316-22. PubMed ID: 16187464 [TBL] [Abstract][Full Text] [Related]
30. Real-time asthma outreach reduces excessive short-acting β2-agonist use: a randomized study. Zeiger RS; Schatz M; Li Q; Solari PG; Zazzali JL; Chen W J Allergy Clin Immunol Pract; 2014; 2(4):445-456, 456.e1-5. PubMed ID: 25017534 [TBL] [Abstract][Full Text] [Related]
31. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population. Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006 [TBL] [Abstract][Full Text] [Related]
32. Obtaining optimal control in mild asthma: theory and practice. Watson L; Kerstjens HA; Rabe KF; Kiri V; Visick GT; Postma DS Fam Pract; 2005 Jun; 22(3):305-10. PubMed ID: 15805133 [TBL] [Abstract][Full Text] [Related]
33. Prescription of oral short-acting beta 2-agonist for asthma in non-resource poor settings: A national study in Malaysia. Chin MC; Sivasampu S; Khoo EM PLoS One; 2017; 12(6):e0180443. PubMed ID: 28662193 [TBL] [Abstract][Full Text] [Related]
34. Comparative effectiveness of budesonide-formoterol combination and fluticasone-salmeterol combination for asthma management: a United States retrospective database analysis. Tunceli O; Williams SA; Kern DM; Elhefni H; Pethick N; Wessman C; Zhou S; Trudo F J Allergy Clin Immunol Pract; 2014; 2(6):719-26. PubMed ID: 25439363 [TBL] [Abstract][Full Text] [Related]
35. The lag-time approach improved drug-outcome association estimates in presence of protopathic bias. Arfè A; Corrao G J Clin Epidemiol; 2016 Oct; 78():101-107. PubMed ID: 26976053 [TBL] [Abstract][Full Text] [Related]
36. Association between consistent omalizumab treatment and asthma control. Lafeuille MH; Gravel J; Zhang J; Gorsh B; Figliomeni M; Lefebvre P J Allergy Clin Immunol Pract; 2013 Jan; 1(1):51-7. PubMed ID: 24229822 [TBL] [Abstract][Full Text] [Related]
37. Risk of asthma exacerbation, asthma-related health care utilization and costs, and adherence to controller therapy in patients with asthma receiving fluticasone propionate/salmeterol inhalation powder 100 μg/50 μg versus mometasone furoate inhalation powder. Hagiwara M; Delea TE; Stanford RH J Asthma; 2013 Apr; 50(3):287-95. PubMed ID: 23305687 [TBL] [Abstract][Full Text] [Related]
38. Compliance with the Canadian Association of Emergency Physicians' asthma clinical practice guidelines at a tertiary care emergency department. Filiatrault L; Harriman D; Abu-Laban RB; Mark FitzGerald J; Chahal AM; Douglas McKnight R CJEM; 2012 Jul; 14(4):224-32. PubMed ID: 22813396 [TBL] [Abstract][Full Text] [Related]
39. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma. Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410 [TBL] [Abstract][Full Text] [Related]
40. Quality of care for acute asthma in emergency departments in Japan: a multicenter observational study. Hasegawa K; Chiba T; Hagiwara Y; Watase H; Tsugawa Y; Brown DF; Camargo CA; J Allergy Clin Immunol Pract; 2013; 1(5):509-15.e1-3. PubMed ID: 24565623 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]